Renovaro Inc.

About Renovaro Inc.

Renovaro Bio AI focuses on leveraging a full-stack Bio-AI platform for biomarker discovery and cancer diagnostics to improve outcomes for cancer and neurology patients. Their mission is to advance precision medicine by integrating advanced technology and clinical insight across the continuum of care, from screening to treatment.

Products & Services

AI Drug Discovery & Precision Medicine:A platform using machine learning and predictive analytics for biomarker discovery, accelerating drug discovery, and personalizing treatments for diseases like cancer.

Cancer Diagnostics:Utilizes liquid biopsy and AI to detect diseases earlier and improve treatment outcomes.

Neurology Diagnostics (Augusta Platform):A unique platform combining Cube technology and BioSymetrics' tools for neurological disease diagnosis and therapeutic development.

Immunotherapy & Gene Therapy:Specializes in genetic modification of dendritic cells to fight cancer and immune-mediated diseases.

Specialties

AI Drug Discovery Precision Medicine Cancer Diagnostics Biomarker Discovery Neurology Diagnostics Immunotherapy Gene Therapy Machine Learning in Healthcare

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: STTR Grant T: - FT: STTR Grant	A: 1850000 MR: - FA: $1.85M USD FAN: 1850000	D: 2025-09-11 FD: 2025-09-11	1 investors
2	RT: Equity T: - FT: Equity	A: 15000000 MR: - FA: 15 million FAN: 15000000	D: 2025-02-26 FD: 2025-02-26	-
3	RT: Grant T: - FT: Grant	A: 250000000 MR: - FA: over €250M FAN: 250000000	D: 2024-12-23 FD: 2024-12-23	1 investors

STTR Grant Latest

2025-09-11

$1.9M

1 investor (Pro only)

Equity 2025-02-26

$15.0M

Grant 2024-12-23

$250.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Renovaro Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised